Atlas Trials

A Randomized, Double-blinded, Self-controlled Clinical Study of Intralesional Injection of 5-fluorouracil Plus Triamcinolone for the Treatment of Refractory Nodular Prurigo

Clinical trial NCT06524323 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06524323
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Nodular Prurigo
Start date
2024-09-01
Primary completion
2026-08-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.